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Abstract
Objective: To compare the risk of complications associated with benign hysterectomy according 
to surgical method. 
Design: Register-based prospective cohort study 
Setting: Danish Hysterectomy Database 2004 to 2015 
Population: All Danish women with benign elective hysterectomy (N =51,141)
Methods: Multivariate log-binomial regression to compute relative risks (RRs) stratified by 
calendar period, and adjusted for age, height, weight, smoking habits, use of alcohol, comorbidity, 
indications, uterine weight, and adhesions. Multiple imputation and ‘intention to treat’ analyses 
were performed. 
Main outcome measures: Major (Grade III-V) and minor (Grade I-II) Clavien-Dindo modified 
complications within 30 days.  
Results: Overall, major complications occurred in 3,577 (7.0%) hysterectomies and minor 
complications in 4,788 (9.4%). The proportions of major and minor complications according to 
type of hysterectomy were 10.3% and 9.6% for abdominal (AH), 4.1% and 12.1% for laparoscopic 
(LH), 4.9% and 8.0% for vaginal (VH) for non-prolapse and 2.3% and 6.4% for prolapse. 
In multivariate analyses, compared to VH for non-prolapse, the risk of major complications was 
higher for AH [RR=1.82 (1.63-2.03)] but lower for both LH [RR=0.78 (0.68-0.90)] and VH for 
prolapse [RR=0.55 (0.41-0.75)] . For LH, the risk of major complications reduced from a RR=0.96 
(0.75-1.22) in the time period 2004-2009 to a RR=0.72 (0.60-0.87) between 2010-2015. 
Conclusion: Laparoscopic hysterectomy and VH for uterine prolapse are associated with fewer 
major complications, but AH is associated with more major complications, compared to VH 
performed in the absence of uterine prolapse.   
Funding: The database is supported by the Danish Health Authorities (Danish Clinical Registries) 
as one of the 60 databases in Denmark. The grants are for the annual working reports and the 
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Introduction
The recommendations and practices regarding methods for hysterectomy are changing 
internationally. According to the Cochrane review 2015 vaginal hysterectomy (VH) was still the 
best minimal access method for hysterectomy, but benefits and hazards seem to be dependent 
on the surgical expertise1. Moreover, the authors recommend the evidence in this review to be 
interpreted with caution as adverse event rates were low, resulting in low power for these 
comparisons1. 
In daily practice VH is preferred for prolapse, but for other indications the ultimate decision 
depends upon the size and shape of uterus. Some favour laparoscopic hysterectomy (LH) over 
VH in general2,3, some favour VH even for enlarged uteri4, others consider that LH is preferable 
when concomitant salpingectomy or oophorectomy is needed4,5. The importance of the shared 
decision-making process is highlighted1,6, and as the techniques improve, frequent re-evaluations 
may be needed6.  
Some countries uphold high rates of VH: In Sweden they have 27% VH for non-prolapse (VHnp)7. 
Most countries report VHnp and VH for prolapse (VHp) together: Finland, Netherlands and 
Austria have 44%, 51%, and 47% respectively8-10. USA and Portugal report 19% and 21% 
respectively11,12. In other countries, UK, Australia, and Denmark, LH is replacing both VHnp and 
abdominal hysterectomy (AH)13-15. In the 1990s most of the hysterectomies in Denmark were 
performed as AH16. In the 2000s, VHnp increased but only reached 20%17,18. From 2010 a 
national implementation of LH has begun to replace AH, and LH became the most common 
method15. 
In 2004 we established the hysterectomy database, prospectively registering patient-related 
factors and all postoperative complications with 100% follow-up in the National Patient Register 
(NPR)19-21. The aim of this national population-based study is to compare the overall 
complications within 30 days after benign elective hysterectomy according to methods and 
calendar periods, controlled for patient-related confounders. A complete cohort of all benign 
hysterectomies including more than 50,000 patients, allows comparison of complications of 
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Methods
In the early 2000s, a nationwide Danish Hysterectomy Database was established by 
gynaecologists from different regions in Denmark19. This effort to reduce complications and 
diminish regional variation was supported by The Danish Health Authority. They funded the work 
for further evidence-based knowledge for national recommendations regarding hysterectomy20. 
The Danish Clinical Registers funded the database as well as annual national audit meetings and 
reports15. We have no patients in the database. All postoperative complications treated at the 
hospitals were registered with 100% follow-up in the National Patient Register (NPR)21. 
In Denmark the national public health care system is free of charge for all inhabitants with a 
specific ten-digit-social security number in the Danish Civil Registration System (CPR) through 
life. It is mandatory to record operations, diagnoses, patient-related characteristics, and any 
readmission to the NPR. The registration of readmissions is linked to the primary operation by 
CPR. Of the total number of hysterectomies, eight percent are performed in private hospitals, 
primarily for women with supplementary private healthcare insurance to cut waiting time. The 
private hospitals also report to the NPR15.
Validation of data
Nationwide, each surgeon fills in a mandatory form including various patient characteristics and 
specific information about the operation and the local secretaries report the codes to the NPR. 
From 2004 to 2011 all data in the NPR were scrutinized by one single database secretary who 
compared registry data to the original forms. She retrieved missing NPR data from the surgeons 
(forms had to be refilled, and hospital records were rechecked). 
At the national audit-meetings representatives from all gynaecological departments in Denmark 
discuss the results from the different departments, followed by validation of local procedures and 
readmissions to ensure correct benchmarking in the public reports. Ten quality indicators were 
defined in 2004 (and revised annually 2011-2017) and have been published in annual database 
working reports including the last three consecutive years for comparisons, with the purpose to 
conduct quality assessment and further validation both on a local and a national level: Total 
number of benign hysterectomies, number of minimally invasive methods, prophylactic antibiotics, 
length of stay, total and major complications and mortality within 30 days, readmissions and re-
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A register-based prospective national cohort study of all elective benign hysterectomies in 
Denmark from January 2004 to April 2015. In this study, we investigated the hospital-related 
major and minor short-term complications within 30 days postoperatively related to different 
surgical methods.
Study population
51,141 elective benign hysterectomies performed for gynaecological indications, registered in 
NPR with exclusion of emergency cases, postpartum cases, and all gynaecological cancer cases. 
We included cervical dysplasia and endometrial hyperplasia without atypia. Further cases of other 
cancer diagnoses were excluded except for non-melanoma skin cancer. Additionally, 
hysterectomies concomitant to complex benign bowel surgery performed at non-gynaecological 
departments were excluded due to non-gynaecological indications.  
Intervention and outcomes
We subdivided hysterectomy into four groups: AH (total and subtotal), LH (robotic and 
laparoscopic assisted vaginal ), VHnp (cases with a decision-making process regarding the 
feasibility of vaginal or laparoscopic approach), and VHp (where a laparoscopic approach would 
not normally be clinically useful) by use of the Danish version of the Nordic NCSP, NOMESCO 
Classification of Surgical Procedure (Table S1). 
We extracted complications within 30 days using ICD-10 classification codes for diseases and the 
Nordic Medico-Statistical Committee’s classification of surgical procedures (NCSP 1996-present) 
directly from the NPR. The outcomes were originally defined by the steering committee in 2003. 
The latest adjustment is according to modified Clavien-Dindo classification which is internationally 
accepted as core outcomes for postoperative complications. In this study we used the current 
algorithm from 2018 on the data from 2004-2015 for the first time, thus these results differ from 
the annual working reports. 
Major complications included per-operative bleeding of more than 1000ml, serious infections with 
sepsis, all organ lesions (bowel, bladder or ureteral), all thrombotic-embolic events, any 
reoperation regarding organ lesions, bowel obstruction, infection or haemorrhage, (including 
ureteral catherization postoperatively), and all wound complications requiring operative treatment 
(haematoma, rupture, or abscess), major anaesthetic complications, shock, and death. Mortality 
was searched as a non-vital status in the CPR. We also linked to the Cause of Death Register. 
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Total complications were defined as any deviation from normal postoperative course, all re-visits 
regardless of the diagnosis and need for treatment, including minor therapeutic regimens and 
small wound infection, and observations for comorbidity conditions postoperatively as modified 
Clavien-Dindo classification grade I-V22,23. Minor complications were calculated from total minus 
major. 
Clinical data were also collected for age, height and weight as body mass index (BMI) 
(categorised <18.5, 18.5-24.9, 25-30, >30), smoking habits, use of alcohol, comorbidity 
(according to the American Society of Anaesthesiologists, ASA groups one to four) and uterine 
weight (categorised <300, 300-499, 500-999, >=1000gram). Diagnoses were according to the 
International classification of diseases ICD-10 diagnoses since 1990 and the indication for 
surgery categorised into one of eight exclusive subgroups (Table 1 and Table S2). Abdominal 
adhesions after previous surgery or inflammation were recorded. Data were stratified for the 
calendar periods 2004-2009 and 2010-2015, because the latter period coincided with the national 
implementation of LH.
Missing data
There were no missing data for any hysterectomy procedure, additional procedures, or 
readmissions used to define the major complications. All these data are mandatory to register in 
NPR and the method by which the national funds are disbursed. Thus, we have 100% follow-up 
for the complications. However, for uterine weight, body mass index, smoking, comorbidity and 
alcohol use there were some missing data: A total of 19.1% of the cases had incomplete records 
for one or more of the five patient-related variables; uterine weight (0.7%), body mass index 
(11.3%), smoking (10.4%), comorbidity (10.7%), and use of alcohol (14.8%). Uterine weight 
seemed to be missing completely at random (MCAR) and the other four showed a non-response 
pattern (missing at random, MAR). Of 51,141 cases, 41,373 were complete cases 
The non-responses for these patient-related outcomes were more common for private clinics in 
the first calendar period (problems with IT systems), and for all hospitals in the last calendar 
period because the one single database secretary stopped after 2011 (national grant was 
reduced). Thus, the non-response pattern for the confounders was most common for LH (LH 
missing 16-19%, AH missing 9-14%, VHp missing 9-15%, and VHnp missing 6-12%). 
The estimates in the multivariate analysis would thus be biased using complete case analysis as 
missingness is not MCAR. We then analysed the missing values as just another level for the 
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predictors in the analyses. As this method might produce biased estimates, we also performed 
multiple imputation for comparisons of the estimates.  We imputed the five categorical patient-
related variables; uterine weight, body mass index, smoking, comorbidity, and use of alcohol. We 
used the fully conditional method with 50 iterations and 50 imputations in SPSS. For the 
multivariate analyses performed on the imputed datasets, we report the pooled estimates. 
Statistical analyses
Log-binomial regression analyses were carried out to calculate relative risk (RR) and 95% 
confidence interval (CI) for the association between postoperative complications and predictive 
factors, in univariate and multivariate analyses. Predefined clinically important covariates were 
included in the latter. The multivariate analyses were performed as an ‘as treated’ analysis 
(including all cases), as a ‘per protocol’ analysis’ (excluding all the converted cases), and as an 
‘intention to treat’ analysis (including cases as the intended surgery). We tested for interaction 
between method and calendar period, and as it was significant, we present stratified results 
according to calendar periods. The multivariate stratified analysis was repeated after the multiple 
imputation. A p-value below 0.05 was considered as significant and all analyses were performed 
in SPSS Statistics 22.
Assuming a baseline 5% major complication rate with vaginal hysterectomy for non-prolapse and 
a 1% reduction in major complication rates for the laparoscopic hysterectomies. 6,745 cases 
would be required in each group to give a 5% type 1 error rate and 80% type 2 error rate (Chi-
squared test comparing independent proportions). 
The database was approved in 2003 by The Danish Clinical Registries (RKKP). This project was 
approved regularly by the Danish Data Protection Agency (j.nr. 2012-41-1218): 2011.09.01, 
2016.12.01, and 2019.03.28. Informed consent was not required by Danish law as all data are 
retrieved from administrative registers. 
Results
Characteristics of the study population:
Distribution of all the patient-related characteristics according to the method of hysterectomy is 
listed in Table 1. The surgical methods were used differently according to different indications and 
age groups. LH and VHnp was used less with increasing age, and VHp was most common in 
women over 55. AH was used for uteri with higher weight and leiomyomas, whereas LH was used 
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used less if adhesions were expected and LH if comorbidity was present, and there was an 
increasing use of LH in the last calendar period.  
Nationally there were 51,141 hysterectomies, of these 4,788 (9.4%) had minor and 3,577 (7.0%) 
had major complications. The crude frequencies of postoperative complications within the first 30 
days (minor, major, or mortality alone) according to the different covariates and methods are 
presented in Table 2. Major and minor complications varied especially with the type of 
hysterectomy, indication, comorbidity, uterine weight, BMI, calendar year and presence of 
adhesions. 
Mortality decreased with calendar time, increased with age, was higher in women with 
comorbidity, and adhesions, and when the hysterectomy was performed as VHnp or as AH for 
large benign cysts with initial suspicion of malignancy. Out of 14 fatal cases, 11 were in the first 
calendar period 2004-2009, age over 55, for small uteri without adhesions, performed as AH or 
as VHp. 
Length of stay: 
Length of stay was longer for AH than any other method with 37.2% of AH staying more than five 
days and only 8% below 24 hours. Whereas length of stay was shorter for LH than any other 
method with 8.7% of LH staying more than five days and 37% below 24 hours. Length of stay 
over 5 days was associated with high number of major and minor complications, 29.1% and 
16.2% respectively, but 65.3% of those who stayed more than 5 days did not have any 
complications. Women with a length of stay below 24 hours had lower major, but not lower minor 
complications compared to average, 4.0% and 9.1% respectively. 
Conversions:
There were 48 conversions of 51,141 (0.1%),  (Table S1). Eight of the 48 (16.7%) had major 
complications. Of the intended LH, 20 were converted to AH and 1 to VH. Of the intended VH, 13 
were converted to AH and 3 to LH. Of the intended TAH, 5 were converted to SAH. The 
remaining 6 were recoded to another type of LH or due to concomitant procedures to VH. 
Predictive risk factors for postoperative complications in univariate analyses:
AH had higher risk of major complications compared to VHnp [RR=2.08 (1.88-2.30)], but LH had 
less [RR=0.83 (0.73-0.95)] (Table 3). Major complications increased with leiomyomas, abnormal 
uterine bleeding, endometriosis, ovarian cysts (concomitant), larger uteri, adhesions, larger BMI, 









This article is protected by copyright. All rights reserved
complications compared to VHnp. Regarding minor complications, both AH [RR=1.20 (1.11-1.31)] 
and LH [RR=1.50 (1.37-1.65)] were associated with higher risk than VHnp (Table 3). Minor 
complications increased with younger age, smaller uteri, adhesions, larger BMI, comorbidity, 
endometriosis, dysplasia, pain, and calendar time. 
We included the missing values as a separate level in the categorical predictors (Table 3) in the 
univariate analyses, and the missing categories were nearly all significantly associated with fewer 
complications (Table 3). 
Predictors for complications in multivariate analyses 
AH had higher risk of complications [RR=1.82 (1.63-2.03)] whereas both LH [RR=0.78 (0.68-
0.90)] and VHp [RR=0.55 (0.41-0.75)] had lower risk compared to VHnp. Both AH [RR=1.33 
(1.22-1.46)] and LH [RR=1.48 (1.35-1.63)] remained associated with more minor complications 
than VHnp (Table S4). The confounders included were age, indication, comorbidity, BMI, use of 
tobacco and alcohol, uterine weight, calendar period and adhesions. We performed three 
different analyses: ’as treated’, ‘per protocol’, and ‘intention to treat’. The estimates were 
practically unchanged (Table S4).
Calendar trend:
There was a significant interaction between LH and calendar period for both minor and major 
complications, thus we used stratified analyses. National implementation of LH began in 2010-
201515, and the risk of major complications decreased after LH [RR=0.72(0.60-0.87)], while the 
risk for minor increased [RR=1.55 (1.36-1.77)] both compared to VHnp (Table 4). We only had 40 
robotic cases in the first calendar period. Robotic cases had only 3% major complications (Table 
S1).  
We developed one set of multivariate analyses using the data with the missing values coded as 
separate categories and another using imputed data and a pooled estimate from the 50 imputed 
dataset. However, the estimates remained practically unchanged (Table 4).
Weight trend: 
In the multivariate analyses (Table 4), major complications increased with larger uterine weight 
independent of the method. In total there were 1,934 uteri over 1,000 grams, of these 151 (7.1%) 
with minor and 382 (20.4%) with major complications. The proportion of major complications after 
AH were dependent on uterine weight <300 grams, 300-499 grams, 500-999 grams, and >1000 
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were 3.9%, 4.6%, 6.2% and 14.6% respectively, and after VHnp 4.8%, 4.7%, 7.0%, 25.9% 
respectively. In the multivariate analysis (Table 4) the relative risk of major complications for 
uterine weight <300, 300-499, and 500-999grams respectively, all compared to >=1000grams, 
were RR=0.42 (0.37-0.47), RR=0.45 (0.40-0.52), and RR=0.57 (0.50-0.64) respectively. For 
smaller uterine weight, LH and VHnp were comparable, and for larger uterine weight LH had 
fewer major complications than both VHnp and AH (Table S5). 
Factors associated with major and minor complications:
To further explore the 4,788 minor complications, they were divided into 13 groups according to 
the diagnoses used in the register (Table S3): There were 32% postoperative bleeding 
complications, 30% infections, and 21% with unspecified pain, none of which required 
reoperations. 
In the final analyses (Table 4), the independent predictors for increased risk of major 
complications were larger uterine weight and higher BMI in both periods. Comorbidity and 
endometriosis were significant predictors in 2004-09, whereas abnormal uterine bleeding and 
hyperplasia/dysplasia became significant in 2010-15. Adhesions were an independent predictor 
for increased major and minor complications in both periods. The independent predictors for 




LH was associated with a lower risk of major complications within 30 days of surgery, compared 
to VHnp, even in the calendar period following national implementation, where a national learning 
curve was expected to go from experts to general gynaecologists. This risk difference was even 
more apparent when uterine weight was over 500 grams. AH had a higher risk for major 
complications compared to VHnp both before and after the national implementation of LH. 
Strength and Limitations  
We used a comprehensive, nationwide data set of all hysterectomies and a mandatory 
registration of all operations, in public as well as in private hospitals. All patients can be treated at 
public hospitals regardless of economic status and without any costs, minimising the risk of 
socioeconomic bias. Mortality data were validated with cause of death certificates. Data regarding 
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inexplicable complication was checked with the hospital records in connection with the national 
audit meeting. 
In general, the randomised controlled trial (RCT) is considered the gold standard study design to 
compare different treatment methods as regards internal validity. In this cohort study, the different 
methods were not equally used for different patient characteristics. However, this long-term real-
world study of evidence-based practice in a national population might have external validity24. It 
allows representation of heterogeneity among the participants in an everyday setting, choosing 
the methods most suitable for the individual patient. We got the same results regardless of the 
analysis approach: ‘as treated’ analysis, ‘per protocol’, and ‘intention to treat’. 
Limitations include a potential overestimation of minor complications because all re-visits are 
automatically registered with a tentative complication diagnosis, although only part of them have 
a complication requiring treatment. Re-visits increased as the LH implementation went national. 
Intended outpatient-operations became registered as re-visits, and the reduced length of stay 
also caused more re-visits. This apparent increase in minor complications may also reflect 
surveillance bias because more intense follow up may have been instituted with a new surgical 
technique, less familiar. On the other hand, the complications included in our analysis relate to 
readmissions to hospital, and not those seen by the general practitioners. Thus this may cause 
an underestimation of the number of minor complications across all hysterectomy methods. 
However, it is unlikely that major complications would be missed as these invariably necessitate 
hospital readmission.
We had 1-15% missing values for five patient-related covariates and included them as separate 
categories in our multivariate analysis, which might produce biased estimates. However, we got 
the same results from analysis on the imputed dataset.  We did not have enough robotic 
hysterectomies to analyse if there was any difference between laparoscopic and robotic surgery. 
Interpretation: 
In 2004-09 LH was performed by relatively few experts but had the same complications as VHnp. 
From 2010 LH was implemented nationally and had fewer complications than VHnp15. The risk of 
major complications increased with larger uterine weight, higher BMI and adhesions, but 
independently of these patient-related factors and the learning curve, LH seems favourable to 
VHnp and AH. During the implementation years of LH, unfortunately we had some cases with 
sarcomas after uncontained morcellation25. In 2015 the Danish Health Authority recommended 
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implementation of contained morcellation will influence the superiority of LH compared to VHnp in 
Denmark26. 
International comparisons of complications
The Cochrane review included 16 studies with 1,440 women comparing LH and VH and found no 
evidence of a difference between the groups for any of the primary outcomes, nor for ureteral 
injuries1. There are only few national population-based studies of complications to hysterectomy. 
In Sweden 2009-2015, they excluded VHp, and found that VHnp and LH did not differ significantly 
in complications7.  A Finnish study included VHp in their analysis and found LH to have less 
complications than VH in 1996, but VH had less in 20068. We subdivided VH to explore the 
differences. The patients having a VHp were older, with more comorbidity, smaller uteri, less 
adhesions, and were not usually considered for laparoscopic approach. Thus, we chose to 
compare LH with VHnp. After national implementation of LH from 2010, LH had fewer major 
complications. The increase of minor complications for LH might be a mixed result of a general 
cautious monitoring of a new method, and our comprehensive registration.  
Conclusion 
In Denmark, LH for benign hysterectomy had fewer major complications than both AH and VHnp, 
independent of uterine weight. Continuing monitoring of rates and complications after different 
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  total % of method in each subgroup 
All  51,141 49.2 19.7 15.4 15.7 
Age <40 6,509 41.8 29.2 3.3 25.7 
 40-44 11,187 51.5 22.9 3.3 22.3 
 45-49 13,995 57.4 21.6 4.1 16.9 
 50-54 7,465 60.1 18.4 9.6 11.9 
 >=55 11,985 34.8 9.9 50.1 5.2 
Indicationsa Leiomyomas 22,008 69.9 16.8 1.6 11.7 
 AUB, all 10,878 40.0 22.5 1.3 36.2 
 Endometriosis 989 52.6 38.7 1.0 7.7 
 Prolapse+incont 7,375  3.3  1.5 94.6 0.6 
 Hyperpl+dyspl 1,530 36.3 34.3 2.8 26.6 
 Dysp+dysm+pain 1,959 41.8 30.7 0.1 27.4 
 Obs cancer/cysts 1,686 91.0 7.5 0.0 1.5 
 Genetic+other 4,716 37.3 45.8 7.4 9.5 
Comorbidityb  Unknown 5,473 43.0 34.1 14.1 8.8 
1-2 44,914 49.9 18.0 15.4 16.7 
3-4 754 54.2 8.1 26.8 10.9 
Body Mass Indexc Unknown 5,779 45.6 28.7 15.4 10.3 
 < 18.5 709 46.2 22.6 10.6 20.6 
 18.5-24.9 21,523 49.0 19.2 15.0 16.8 
 25-30 14,398 49.1 16.9 18.4 15.6 
 >30 8,732 52.7 18.8 12.0 16.5 
Smoking Unknown 5,301 43.0 31.1 15.6 10.3 
 No 32,248 49.0 18.7 18.0 14.3 
 yes 13,592 52.1 17.5 9.0 21.4 
Alcohol used Unknown 7,590 47.9 23.8 15.9 12.4 
 0 26,863 49.2 19.5 15.6 15.7 
 1-7/week 13,113 47.9 18.6 15.3 18.2 
 8-14/week 819 55.6 16.1 13.9 14.4 
 >14/week 2,756 62.3 12.6 12.3 12.8 
Uterine weight unknown 372 61.0   9.4 15.1 14.5 
 <300gr 38,085 38.4 22.1 20.3 19.2 
 300-499gr 5,364 69.8 19.6 1.1 9.5 
 500-999gr 5,386 87.4 9.4 0.3 2.9 
 >=1000gr 1,934 95.7 2.5 0.4 1.4 
Calendar yrs 2004 - 2009 27,772 59.7 6.5 15.3 18.5 
 2010 - 2015 23,369 36.8 35.2 15.5 12.5 
Adhesions No 49,140 48.2 19.5 16.0 16.3 
 Yes 2,001 73.3 23.8 0.7 2.2 
Length of stay 0-1 day 8,303 24.3 44.8 18.2 12.7 
2-3 days 20,483 35.5 23.1 19.1 22.3 
More than 3 days 22,355 71.0  7.2 11.0 10.8 
a Indications: AUB = Abnormal uterine bleeding, incont= urge and stress incontinence, Hyperpl+dyspl= 
endometrial hyperplasia without atypia and dysplasia of the cervix, Dysp+dysm+pain= dyspareunia 
+dysmenorrhoea +other pain. b ASA (American Society of Anaesthesiologists). c Body mass index = weight 
in kilograms kg/height in metres squared m2. d Alcohol = units of alcohol (12gram alcohol) per week.
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Table 2: Percentages of minor and major complications and per mille mortality within 30 days after benign 
hysterectomy in Denmark from 2004 to 2015 according to predictive risk factors. 
 
Predictors Subgroups  N Minor n (%) Major n (%) Mortality n (‰) 
Total population  51,141 4,788   (9.4) 3,577   (7.0) 14 (0.28) 
Hysterectomy AH 25,165 2,426   (9.6) 2,586 (10.3) 7 (0.28) 
LH 10,046 1,213 (12.1)    414   (4.1) 2 (0.20) 
VH prolapse 7,883     503   (6.4)    179   (2.3) 4 (0.51) 
VH non-prolapse 8,047    646   (8.0)    398   (4.9) 1 (0.12) 
Age <40 6,509    795 (12.2)   489   (7.5) 0      (0) 
40-44 11,187 1,161 (10.4)   862   (7.7) 1 (0.09) 
45-49 13,995 1,335   (9.5) 1,101   (7.9) 2 (0.14) 
50-54 7,465    622   (8.3)   557   (7.5) 0      (0) 
>=55 11,985    875   (7.3)   568   (4.7) 11 (0.92) 
Indicationsa Leiomyomas 22,008 2,033   (9.2) 1,913   (8.7) 2 (0.09) 
AUB, all 10,878 1,138 (10.5)    760   (7.0) 2 (0.18) 
Endometriosis 989   131 (13.2)   108 (10.9) 0      (0) 
Prolapse+incont 7,375   486   (6.6)   181   (2.5) 5 (0.68) 
Hyperpl+dyspl 1,530   120   (7.8)    92   (6.0) 1 (0.65) 
Dysp+dysm+pain 1,959   280 (14.3)   124   (6.3) 0      (0) 
Obs cancer/cysts 1,686  147   (8.7)   136   (8.1) 3 (1.78) 
Genetic+other 4,716  453   (9.6)   263   (5.6) 1 (0.20) 
Comorbidityb Unknown 5,473   461   (8.4)   284   (5.2) 3 (0.55) 
1-2 44,914 4,203   (9.4) 3,203   (7.1) 6 (0.13) 
3-4 754   124 (16.4)    90 (11.9) 5 (6.63) 
BMIc Unknown 5,779   457   (7.9)   293   (5.1) 3 (0.52) 
< 18.5 709   76 (10.7)     68   (9.6) 0      (0) 
18.5-24.9 21,523 2,151 (10.0) 1,432   (6.7) 7 (0.33) 
25-30 14,398 1,262   (8.8)   964   (6.7) 2 (0.14) 
>30 8,732 842   (9.6)   820   (9.4) 2 (0.23) 
Smoking Unknown 5,301   421   (7.9)    241  (4.5) 3 (0.57) 
No 32,248 2,921   (9.1) 2,321   (7.2) 6 (0.19) 
yes 13,592 1.446 (10.6) 1,015   (7.5) 5 (0.37) 
Alcohol used Unknown 7,590 645   (8.5)   418   (5.5) 4 (0.53) 
0 26,863 2,625   (9.8) 1,998   (7.4) 8 (0.30) 
1-7/week 13,113 1,188   (9.1)   911   (6.9) 2 (0.15) 
8-14/week 2,756   254   (9.2)   188   (6.8) 0      (0) 
>14/week 819   76   (9.3)    62   (7.6) 0      (0) 
Uterine weight Unknown 372    28   (7.5)     20   (5.4) 0      (0) 
<300gr 38,085 3,659   (9.6) 2,165   (5.7) 11 (0.29) 
300-499gr 5,364   486   (9.1)   420   (7.8) 1 (0.19) 
500-999gr 5,386 477   (8.9)   577 (10.7) 2 (0.37) 
>=1000gr 1,934   138   (7.1)   395 (20.4) 0      (0) 
Calendar yrs 2004 - 2009 27,772 2,394   (8.6) 2,004   (7.2) 10 (0.36) 
2010 - 2015 23,369 2,394 (10.2) 1,573   (6.7)  4 (0.17) 
Adhesions No 49,140 4,503   (9.2) 3,300   (6.7) 13 (0.26) 
Yes 2,001   285 (14.2)   277 (13.8) 1 (0.50) 
a Indications: AUB = Abnormal uterine bleeding, incont= urge and stress incontinence, Hyperpl+dyspl= 
endometrial hyperplasia without atypia and dysplasia of the cervix, Dysp+dysm+pain= dyspareunia+ 
dysmenorrhoea+other pain. b ASA (American Society of Anaesthesiologists). c BMI = body mass index = 
weight in kilograms kg/height in metres squared m2. d Alcohol is units of alcohol (12gram) per week.
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Table 3: Relative Risk (95% confidence interval) for minor and major complications within 30 days after 
benign hysterectomy (log-binomial regression) according to predictors 2004 to 2015.  
Predictors Subgroups N Minor complications Major complications 
Hysterectomy AH 25,165 1.20 (1.11-1.31)* 2.08 (1.88-2.30)* 
LH 10,046 1.50 (1.37-1.65)* 0.83 (0.73-0.95)** 
VH prolapse 7,883 0.80 (0.71-0.89)* 0.46 (0.39-0.55)* 
VH non-prolapse 8,047 ref ref 
Age <40 6,509 1.67 (1.53-1.83)* 1.59 (1.41-1.78)* 
40-44 11,187 1.42 (1.31-1.55)* 1.63 (1.47-1.80)* 
45-49 13,995 1.31 (1.20-1.42)* 1.66 (1.51-1.83)* 
50-54 7,465 1.14 (1.03-1.26)* 1.57 (1.41-1.76)* 
>=55 11,985 ref ref 
Indicationsa Leiomyomas 22,008 0.96 (0.87-1.06) 1.56 (1.38-1.77)* 
AUB, all 10,878 1.09 (0.98-1.21) 1.25 (1.09-1.44)* 
Endometriosis 989 1.38 (1.15-1.65)* 1.96 (1.58-2.42)* 
Prolapse+incont 7,375 0.69 (0.61-0.78)* 0.44 (0.37-0.53)* 
Hyperpl+dyspl 1,530 0.82 (0.67-0.99)*** 1.08 (0.86-1.36) 
Dysp+dysm+pain 1,959 1.49 (1.29-1.71)* 1.14 (0.92-1.40) 
Obs cancer/cysts 1,686 0.91 (0.76-1.08) 1.45 (1.19-1.77)* 
Genetic+other 4,716 ref ref 
Comorbidityb Unknown 5,473 0.51 (0.43-0.62)* 0.44 (0.35-0.54)* 
1-2 44,914 0.57 (0.48-0.67)* 0.60 (0.49-0.73)* 
3-4 754 ref ref 
BMIc Unknown 5,779 0.82 (0.74-0.91)* 0.54 (0.47-0.61)* 
< 18.5 709 1.11 (0.89-1.39) 1.02 (0.81-1.29) 
18.5-24.9 21,523 1.04 (0.96-1.12) 0.71 (0.65-0.77)* 
25-30 14,398 0.91 (0.84-0.99)*** 0.71 (0.65-0.78)* 
>30 8,732 ref ref 
Smoking Unknown 5,301 0.75 (0.67-0.83)* 0.61 (0.53-0.70)* 
No 32,248 0.85 (0.80-0.90)* 0.96 (0.90-1.04) 
yes 13,592 ref ref 
Alcohol used Unknown 7,590 0.92 (0.73-1.15) 0.73 (0.56-0.94)*** 
0 26,863 1.05 (0.85-1.38) 0.98 (0.77-1.25) 
1-7/week 13,113 0.98 (0.78-1.22)  0.92 (0.72-1.18) 
8-14/week 819 0.99 (0.79-1.27) 0.90 (0.68-1.19) 
>14/week 2,756 ref ref 
Uterine weight unknown 372 1.06 (0.71-1.56) 0.26 (0.17-0.41)* 
<300gram 38,085 1.35 (1.14-1.59)* 0.28 (0.25-0.31)* 
300-499gram 5,364 1.27 (1.06-1.52)** 0.38 (0.34-0.44)* 
500-999gram 5,386 1.24 (1.03-1.49)*** 0.53 (0.47-0.59)* 
>=1000gram 1,934 ref ref 
Calendar years 2004 - 2009 27,772 0.84 (0.80-0.89)* 1.07 (1.01-1.14)*** 
2010 - 2015 23,369 ref ref 
Adhesions No 49,140 0.64 (0.58-0.72)* 0.49 (0.43-0.54)* 
 Yes 2,001 ref ref 
a AUB = Abnormal uterine bleeding, incont= urge and stress incontinence, Hyperpl+dyspl=endometrial 
hyperplasia without atypia & cervix dysplasia, Dysp+dysm+pain= dyspareunia+dysmenorrhoe+other pain. b 
ASA (American Society of Anaesthesiologists). c BMI = body mass index = weight in kilograms kg/height in 
metres squared m2. d Alcohol is units of alcohol (12gram) per week    *p<=0.001 **P<=0.01 ***P<0.05   
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Table 4: Multivariate log-binomial regression for major and minor complications within 30 days of elective 
benign hysterectomy in Denmark from 2004 to 2015 according to surgical method stratified by calendar 
periods.   
Major complications: multivariate RR (95% CI) by calendar periods 
Method 2004-2009 2010-2015 
 Codeda Imputedb Coded imputed 
AH 1.80 (1.56-2.07)* 1.79 (1.55-2.06)* 1.85 (1.55-2.20)* 1.82 (1.53-2.16)* 
LH 0.96 (0.75-1.22) 0.95 (0.75-1.22) 0.72 (0.60-0.87)* 0.72 (0.60-0.86)* 
VHprolapse 0.76 (0.47-1.23) 0.77 (0.48-1.24) 0.39 (0.25-0.61)* 0.39 (0.26-0.61)* 
VHnon-prolapse ref ref ref ref 
Minor complications: multivariate RR (95% CI) by calendar periods 
AH 1.37 (1.23-1.54)* 1.35 (1.21-1.51)* 1.32 (1.15-1.53)* 1.30 (1.13-1.50)* 
LH 1.26 (1.06-1.49)** 1.25 (1.05-1.48)** 1.55 (1.36-1.77)* 1.53 (1.33-1.74)* 
VHprolapse 0.93 (0.67-1.31) 0.94 (0.67-1.32) 0.90 (0.67-1.21) 0.90 (0.67-1.20) 
VHnon-prolapse ref ref ref ref 
a Including all 51,141 cases. The missing values are coded as a separate category in the patient-related 
predictors as showed in Table 2 and 3.  
b Including all 51,141 cases. The missing values are imputed, the pooled estimate from the 50 imputation 
datasets are presented. 
*p<=0.001 **p<=0.01 ***p<0.05 
Confounder control for age, indication, comorbidity, body mass index, smoking, uterine weight, adhesions 
and use of alcohol. 
Significant predictors for major complications independent of methods:   
In 2004-2009: Endometriosis compared to prophylactic hysterectomy for genetic mutation RR=1.58 (1.18-
2.12). Uterine weight <300 compared to >1000 RR=0.40 (0.35-0.47). Body mass index 18-24 compared to 
>30 RR=0.74 (0.66-0.82). Comorbidity ASA-group 1-2 compared to 3-4 RR=0.54 (0.43-0.67). No abdominal 
adhesions compared to difficult RR=0.57 (0.49-0.66).  
In 2010-2015: Abnormal uterine bleeding [RR=1.24 (1.03-1.50)] and Hyperplasia+Dysplasia [RR=1.40 (1.05-
1.88)] both compared to prophylactic hysterectomy for genetic mutation. Uterine weight <300 compared to 
>1000 RR=0.45 (0.38-0.54). Body mass index 18-24 compared to >30 RR=0.83 (0.74-0.94). No abdominal 
adhesions compared to difficult RR=0.69 (0.58-0.82).  
 
Significant predictors for minor complications independent of methods:   
In 2004-2009: Uterine weight <300 compared to >1000 RR=1.79 (1.38-2.31). Body mass index 18-24 
compared to >30 RR=1.14 (1.02-1.27). Comorbidity ASA-group 1-2 compared to 3-4 RR=0.46 (0.38-0.56).  
No abdominal adhesions compared to difficult RR=0.75 (0.63-0.88).  
In 2010-2015: Endometriosis [RR=1.32 (1.03-1.69)], Hyperplasia+Dysplasia [RR=0.73 (0.56-0.95)], and 
Dyspareunia+Pain [RR=1.69 (1.41-2.03)] all compared to prophylactic hysterectomy for genetic mutation. 
Comorbidity ASA-group 1-2 compared to 3-4 RR=0.65 (0.49-0.87). No abdominal adhesions compared to 
difficult RR=0.75 (0.65-0.88).  
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